Combating Medication Misinformation | Pharmacy Daily

Australian Campaign Addresses Medicines Misinformation Through Deprescribing Initiative

The fourth annual MedsAware Deprescribing Action Week launched today across Australia, focusing on combating health misinformation while promoting safer medication practices. The campaign, running from March 16-20, aims to foster critical conversations between patients, caregivers, and healthcare providers about the risks of polypharmacy and the benefits of deprescribing.

This year’s initiative, spearheaded by Advanced Pharmacy Australia (AdPha), tackles the growing challenge of misleading health information with the theme “Are you MedsAware or misinformed?” In an era where patients frequently encounter contradictory or inaccurate information about medications, pharmacy professionals are positioned as essential guides in ensuring medication decisions remain evidence-based and patient-centered.

“Today, in an era where health information – and misinformation – is more accessible than ever, pharmacists play a vital role in helping people navigate conflicting advice and make evidence-based decisions about their medicines,” said AdPha president Associate Professor Tom Simpson.

The campaign encourages pharmacists to initiate proactive conversations with patients about health information they’ve discovered online, helping them sift through complex and often conflicting sources. This approach supports safer deprescribing practices, the process of reducing or discontinuing medications that may no longer benefit patients or could cause harm.

Dr. Emily Reeve, chair of the Australian Deprescribing Network (ADeN), which founded the MedsAware initiative, emphasized the importance of qualified guidance in an information-saturated environment.

“It’s encouraging to see people taking an active interest in their medicines and their health,” Dr. Reeve noted. “There are some excellent online resources, but with so much information available, it can be hard to know what’s trustworthy. That’s where qualified health professionals make all the difference – helping people navigate the noise and together, make decisions that are safe, effective and right for them.”

The timing of this campaign is particularly relevant as health misinformation continues to proliferate across social media platforms and websites. Studies have shown that misleading health information can lead to inappropriate medication use, delayed treatment, or abandonment of effective therapies. For vulnerable populations, particularly older adults who often manage multiple medications, the consequences can be significant.

Polypharmacy—the concurrent use of multiple medications—presents substantial risks including adverse drug reactions, drug-drug interactions, and medication non-adherence. The Australian Commission on Safety and Quality in Health Care has previously reported that medication-related hospital admissions cost the healthcare system hundreds of millions annually, with a significant proportion being potentially preventable.

AdPha’s campaign provides pharmacists with practical conversation starters and resources to address misinformation tactfully while building trust with patients. These tools are accessible through their dedicated MedsAware hub online.

The initiative aligns with broader national health strategies to improve medication safety and promote patient engagement in treatment decisions. By positioning pharmacists as trusted information mediators, the campaign leverages these professionals’ unique position at the frontline of community healthcare.

Pharmacists across Australia are encouraged to participate by initiating discussions around medication reviews, helping patients understand the quality of their information sources, and collaborating with other healthcare providers to ensure consistent messaging about medications.

As health information continues to grow more accessible but not necessarily more accurate, campaigns like MedsAware Deprescribing Action Week highlight the critical role of healthcare professionals in guiding evidence-based decision-making and ultimately improving medication safety for all Australians.